Abstract

The free beta-subunit of hCG is secreted by several tumors and is reported to be different from native hCG beta. We have developed a monoclonal antibody, B158, specific for free hCG beta to facilitate the detection and isolation of tumor-derived free hCG beta in the presence of intact hCG and hCG alpha. B158 belongs to the immunoglobulin G1 subclass, has high affinity for hCG beta (Ka, 1.05 X 10(9) M-1), and can be obtained in large quantities. The sensitivity of this antibody to detect free hCG beta in a RIA is less than 1 ng. B158 has negligible cross-reactivity with hCG, human LH, and other intact glycoprotein hormones and reacts with the free beta-subunits of deglycosylated hCG, human LH, and ovine LH. The antibody completely inhibits the recombination of hCG beta with hCG alpha indicating the antigenic site to be in the subunit interaction region or its vicinity. Comparison of the amino acid sequences of the various cross-reacting and noncross-reacting hormones indicates that the antigenic site may be discontinuous and conformational. B158 was purified to homogeneity from ascites fluid by DEAE-Affi-Gel blue and hCG beta affinity chromatography. Immobilized pure B158 antibody was used to isolate free hCG beta in a homogeneous form and high yield from BeWo choriocarcinoma cell culture supernatants. This free hCG beta has a slightly higher mol wt than standard hCG beta and recombines normally with hCG alpha. BeWo cells appear to produce only one species of free hCG beta.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.